Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Clinical Investigation of Oral Nitrite in Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (PH-HFpEF)

NCT03015402 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT03015402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03015402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Clinical Investigation of Oral Nitrite in Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (PH-HFpEF)
Lead sponsor
University of Pittsburgh
Phase
Phase 2
Overall status
Completed
Start date
October 30, 2017
Completion date
January 25, 2023
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, pulmonary hypertension secondary